Patent delisted for Eli Lilly drug ADCIRCA

20:09 EDT 16 Apr 2019 | BiotechBlog

Annual Drug Patent Expirations for ADCIRCA Adcirca is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from two suppliers. There are two…
The post Patent delisted for Eli Lilly drug ADCIRCA appeared first on DrugPatentWatch -...

The post Patent delisted for Eli Lilly drug ADCIRCA appeared first on Biotechblog.

Original Article: Patent delisted for Eli Lilly drug ADCIRCA

More From BioPortfolio on "Patent delisted for Eli Lilly drug ADCIRCA"